Does BOTULINUM TOXIN TYPE A Cause Off label use? 1,785 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,785 reports of Off label use have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 47.7% of all adverse event reports for BOTULINUM TOXIN TYPE A.
1,785
Reports of Off label use with BOTULINUM TOXIN TYPE A
47.7%
of all BOTULINUM TOXIN TYPE A reports
786
Deaths
847
Hospitalizations
How Dangerous Is Off label use From BOTULINUM TOXIN TYPE A?
Of the 1,785 reports, 786 (44.0%) resulted in death, 847 (47.5%) required hospitalization, and 714 (40.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 1,785 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
Gastrooesophageal reflux disease (660)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Off label use Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE